This article examines Acinetobacter baumannii (AB), a clinically important gram-negative bacterium that causes nosocomial infections and is increasingly resistant to antibiotics. The study focuses on understanding the genetics and mechanisms of AB pathogenicity and antibiotic resistance. Researchers investigated multiple aspects of AB biology, including its chromosomal organization, genomic structure, and comparative genomics with other Acinetobacter species. The article reviews existing knowledge about AB's resistance mechanisms, virulence factors, and clinical significance. Key findings include characterization of AB's genetic material, analysis of resistance-associated genes, and discussion of how the bacterium evades immune responses. The researchers employed molecular and genomic techniques to identify genes involved in antibiotic resistance and pathogenic mechanisms. The work contributes to understanding why AB has become a major healthcare-associated pathogen and why treatment options are becoming limited. The findings have implications for developing new therapeutic strategies and for understanding the evolution of antibiotic resistance in Acinetobacter species. This comprehensive analysis of AB's molecular characteristics provides foundational knowledge relevant to infection control and the development of new antimicrobial approaches.

Key findings

• Acinetobacter baumannii possesses diverse genetic mechanisms for antibiotic resistance that enable survival in hospital environments and limit treatment options.
• The bacterium's chromosomal organization and genomic structure differ from other Acinetobacter species, contributing to its enhanced pathogenic potential.
• AB employs multiple virulence strategies to evade host immune responses and establish infections.
• Comparative genomic analysis reveals specific genes and genetic elements associated with resistance and pathogenicity in clinical AB isolates.
• Understanding AB's genetic basis for resistance and virulence is essential for developing new antimicrobial interventions and infection control strategies.